Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 6 Months to 36 Months

Comparing Antibiotics and Placebo for Ear Infections in Toddlers

Official title: Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Otitis Media)

Run by University of Pittsburgh · NCT07730814 · Data updated 2026-11-12

This trial tests whether amoxicillin, amoxicillin-clavulanate, or a placebo help reduce symptoms in children with acute otitis media.

More Acute Otitis Media (AOM) trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages6 Months to 36 Months
SexAll
Enrollment1100 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations5 sites (Denver, Colorado and 4 other locations)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedDecember 18, 2031
Study endsMarch 17, 2032
Registry record updatedOctober 20, 2026
Trial IDNCT07730814 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6 months to under 36 months with a clinical diagnosis of acute otitis media.

Probably not a fit

Children for whom antibiotics do not reduce symptoms or who receive a placebo may not experience a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, randomized, double-blind study in which children aged 6 to less than 36 months with acute otitis media receive either amoxicillin, amoxicillin-clavulanate, or a matching placebo. Families and investigators are unaware of the assignment to prevent bias, and daily caregiver-reported symptom diaries track symptom severity. The primary goal is to compare average daily symptom burden across the three treatment groups, adjusting for initial illness severity and fever/age factors. Results aim to inform antimicrobial prescribing decisions for pediatric ear infections and support more targeted use of antibiotics. Secondary analyses will explore whether baseline symptoms, fever, age, or antibiotic response influence outcomes.

Why it matters

Potential benefit: If successful, the study could clarify when antibiotics help children with ear infections and guide more effective, appropriate treatment choices.

How similar studies have gone: Prior research in antibiotic use for AOM has yielded mixed results; this trial adds rigorous, blinded comparison to assess relative benefits.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Age 6 months to \<36 months.
* Clinical diagnosis of AOM.

Exclusion Criteria

* Known allergy or other contraindication to oral amoxicillin or clavulanate
* Prior use of systemic antibiotics in the last 7 days
* History of renal impairment
* History of hepatic impairment
* Phenylketonuria or allergy to aspartame
* History of craniofacial abnormalities
* Concurrent bacterial infection requiring systemic antibiotic therapy (e.g., pneumonia, streptococcal pharyngitis)
* Ill appearance, systemic toxicity, or immunodeficiency
* Incomplete pneumococcal vaccination, defined as receipt of fewer than three doses of a pneumococcal conjugate vaccine
* Parent or caregiver unable to complete study surveys in English or Spanish
* Previous randomization into either MEASURE trial within the last 6 months
* Mastoiditis
* Conjunctivitis
* Temperature ≥39°C and AOM-SOS score ≥35
* Cochlear implants
* Spontaneous tympanic membrane perforation with otorrhea at presentation (participants who develop perforation and otorrhea after consent remain eligible)

Where it's running

  • UPMC Children's Hospital of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • University of Colorado, Denver
    Denver, Colorado, United States
    Not yet recruiting
  • Duke University Hospital
    Durham, North Carolina, United States
    Not yet recruiting
  • Cincinnati Children's Hospital
    Cincinnati, Ohio, United States
    Not yet recruiting
  • Seattle Children's Hospital
    Seattle, Washington, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Nader Shaikh, MD — University of Pittsburgh
  • Study coordinator: Jane Luce, MPH
  • Email: lucej2@upmc.edu
  • Phone: 412-383-7853

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.